News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioLineRx Ltd.'s BL-7010, for the Treatment of Celiac, to be Presented at Two Leading Conferences


5/2/2013 11:40:33 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that the Company was invited to deliver an oral presentation at the 2013 National Education Conference & Gluten-Free Expo, the Celiac Disease Foundation's annual conference, in Pasadena, California. Leah Klapper, Ph.D., General Manager, BioLine Innovations Jerusalem, will present BL-7010, for the treatment of celiac, as part of a session entitled Breaking Therapies Beyond the Gluten-Free Diet, that will take place on May 4.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES